In vivo sequence diversity of the protease of human immunodeficiency virus type 1: Presence of protease inhibitor-resistant variants in untreated subjects

Journal of Virology

Volumn 70, Issue 3, 1996, Pages 2038-2043

  Lech, Walter J ^a   Wang, Greg ^a   Yang, Yan Li ^a   Chee, Ying ^a   Dorman, Karin ^a   Mccrae, Derek ^a   Lazzeroni, Laura C ^b   Erickson, John W ^c   Sinsheimer, Janet S ^a   Kaplan, Andrew H ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; PROTEINASE; PROTEINASE INHIBITOR; VIRUS ENZYME;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; ENZYME ANALYSIS; ENZYME SUBSTRATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS PATHOGENESIS; VIRUS STRAIN;

EID: 9044230526     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.3.2038-2043.1996     Document Type: Article

References (50)

1. Cichutek, K.. H. Mergel, S. Norley, R. Linde, W. Kreuz, M. Gahr, and R. Kurth. 1992. Development of a quasispecies of HIV-1 in vivo. Proc Natl. Acad. Sci. USA 89:7365-7369.
2. Coffin, J. M. 1992. Genetic diversity and evolution of retroviruses Curr Top. Microbiol. Immunol. 176:143-164.
3. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
4. Collins, J. R., S. K. Burt, and J. W. Erickson. 1995. Flap opening in HIV-1 protease simulated by activated molecular dynamics. Nat. Struct Biol. 2:334-338.
5. Condra, J. H., W. Schleif, O. M. Blahy, L. J. Gabryelski, D. J. Graham, J. C. Quintero, A. Rhodes, H. L. Rabbins, E. Roth, M. Shivaprakash, D. Titus, T. Yang, H. Tepler, K. E. Squires, P. J. Deutsch, and E. A. Emini. 1995 In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors Nature (London) 374:569-571.
6. Dickson, C., R. Eisenman, H. Fan, E. Hunter, and N. Teich. 1984. Protein biosynthesis and assembly, p. 513-648. In R. A. Weiss, R A. Teich, H. E Varmus, and J. M Coffin (ed ), Molecular biology of tumor viruses: RNA tumor viruses Cold Spring Harbor Laboratory. Cold Spring Harbor, N Y.
7. di Marzo Veronese, F., M. S. Reitz, Jr., G. Gupta, M. Robert-Guroff, C. Boyer-Thompson, A. Louie, R. C. Gallo, and P. Lusso. 1993. Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker J Biol Chem. 268:25894-25901.
8. el-Farrash, M. A., M. J. Kuroda, T. Kitazaki, T. Masuda, K. Kato, M. Hatanaka, and S. Harada. 1994. Generation and characterization of a human immunodeficiency virus type 1 (HIV-1) mutant resistant to an HIV-1 protease inhibitor J. Virol 68:233-239
9. 8a.Erickson, J. W. Unpublished data.
10. Ferbas, J., A. H. Kaplan, M. A. Hausner, L. E. Hultin, J. L. Matud, Z. Liu, D. Panicali, H. Nerng-Ho, R. Detels, and J. V. Giorgi. 1995. Immunologic and virologic determinants of survival in chronic human immunodeficiency virus infection J. Infect Dis. 172:329-339.
11. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
12. 2-symmetric protease inhibitor. J. Virol. 68:2016-2020
13. Jacobsen, H., K. Yasargil, D. L. Winslow, J. C. Craig, A. Krohn, I. B. Duncan, and J. Mous. 1995. Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959. Virology 206:527-534.
14. 12a.Kaplan, A. H. Unpublished observation.
15. Kaplan, A. H., S. F. Michael, R. S. Wehbie, M. F. Knigge, D. A. Paul, L. Everitt, D. J. Kempf, D. W. Norbeck, J. Erickson, and R. Swanstrom. 1994 Selection of multiple HIV-1 variants with decreased sensitivity to an inhibitor of the viral protease. Proc Natl. Acad. Sci. USA 91:5597-5601.
16. Kaplan, A. H., J. A. Zack, M. Knigge, D. A. Paul, D. J. Kempf, D. W. Norbeck, and R. Swanstrom. 1993. Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectiuus particles. J Virol 67:4050-4055.
17. Kohl, N. E., E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. Dixon, E. M. Scolnick, and I. S. Sigal. 1988. Active human immunodeficiency virus protease is required for viral infectiviry. Proc. Natl. Acad. Sci. USA 85:4686-4690.
18. Kozal, M. J., R. W. Shafer, M. A. Winters, D. A. Katzenstein, and T. C. Merigan. 1993 A mutation in the human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients. J. Infect. Dis. 167:526-532.
19. Kuiken, C. L., G. Zwart, E. Baan, R. A. Coutinho, J. A. van den Hoek, and J. Goudsmit. 1993. Increasing antigenic and genetic diversity of the V3 variable domain of the HIV envelope piotein in the course of the AIDS epidemic. Proc. Natl. Acad. Sci. USA 90:9061-9065
20. Kuroda, M. J., M. A. El-Farrash, S. Choudhury, and S. Harada. 1995. Impaired infectivity of HIV-1 after a single point mutation in the pol gene to escape the effect of a protease inhibitor in vitro. Virology 210:212-216.
21. Larder, B. A. 1992. 3′-Azido-3′-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 36:2664-2669.
22. Lazzeroni, L., and K. Lange. 1995. Markov chains for Monte Carlo tests of genetic equilibrium in multidimensional contingency tables. Stanford University Division of Biostatistics Technical Report no 178.
23. Lin, Y., X. Lin, L. Hong, S. Foundling, R. L. Heinrikson, S. Thaisrivongs, W. Leelamanit, D. Raterman, M. Shah, B. M. Dunn, and J. Tang. 1995. Effect of point mutations on the kinetics and the inhibition of human immunodeficiency virus type 1 protease: relationship to drug resistance. Biochemistry 34:1143-1152.
24. Loeb, D. D., R. Swanstrom, L. Everitt, M. Manchester, S. E. Stamper, and C. E. Hutchinson. 1989. Complete mutagenesis of the HIV-1 protease. Nature (London) 340:397-400
25. Markham, R. B., X. Yu, H. Farzadegan, S. C. Ray, and D. Vlahov. 1995. Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users. J. Infect. Dis. 4:797-804.
26. Markowitz, M., H. Mo, D. J. Kempf, D. W. Norbeck, T. N. Bhat, J. W. Erickson, and D. D. Ho. 1995. Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor. J. Virol. 69:701-706
27. McCutchan, F. E., P. A. Hegerich, T. P. Brennan, P. Phanuphak, P. Singharaj, A. Jugsudee, P. W. Herman, A. M. Gray, A. K. Fowler, and D. S. Burke. 1992. Genetic variants of HIV-1 in Thailand. AIDS Res Hum. Retroviruses 8:1887-1895.
28. McNearny, T., Z. Hornickova, R. Markham, A. Birdwell, M. Arens, A. Saah, and L. Ratner. 1992. Relationship of HIV-1 sequence heterogeneity to stage of disease. Proc. Natl. Acad Sci. USA 89:10247-10251.
29. Milich, L., B. Margolin, and R. Swanstrom. 1993. V3 loop of the human immunodeficiency virus tvpe 1 Env protein: interpreting sequence variability. J. Virol. 67:5623-5634.
30. Mohri, H., M. K. Singh, W. T. Ching, and D. D. Ho. 1993. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. Proc. Natl. Acad. Sci. USA 90:25-29.
31. Nájera, I., Á. Hotguín, M. E. Quiñones-Mateu, M. Á. Muñoz-Fernández, R. Nájera, C. López-Galíndez, and E. Domingo. 1995. pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69:23-31.
32. Norbeck, D. W., and D. J. Kempf. 1991. HIV-1 protease inhibitors. Annu. Rep. Med. Chem. 26:141-150.
33. Otto, M. J., S. Garber, D. L. Winslow, C. D. Reid, P. Aldrich, P. K. Jadhav, C. E. Patterson, C. N. Hodge, and Y. S. Cheng. 1993. In vitro isolation and identification of human immunodeficiency virus (HIV) variants with reduced sensitivity to C-2 symmetrical inhibitors of HIV type 1 protease. Proc. Natl. Acad. Sci. USA 90:7543-7547.
34. Partaledis, J. A., K. Yamaguchi, M. Tisdale, E. E. Blair, C. Falcione, B. Masthera, R. E. Myers, S. Pazhanisamy, O. Futer, A. B. Cullinan, C. M. Stuver, R. A. Byrne, and D. J. Livingston. 1995 In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease. J. Virol. 69:5228-5235.
35. Patick, A. K., R. Rose, J. Greytok, C. M. Bechtold, M. A. Hermsmeier, P. T. Chen, J. C. Barris, R. Zahler, R. J. Colonno, and P. F. Lin. 1995. Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an ammodiol protease inhibitor. J Virol. 69:2148-2152.
36. Pedroza-Martins, L., N. Chenciner, and S. Wain-Hobson. 1992. Complex intra patient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp120 envelope sequence. Virology 191:837-845.
37. Peng, C., B. K. Ho, T. W. Chang, and N. T. Chang. 1989. Role of human immunodeficiency virus type 1-specific protease in core maturation and viral infectivity. J. Virol. 63:2550-2556.
38. Phillips, R. E., S. Rowland-Jones, D. F. Nixon, F. Gothch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza, and A. J. McMichael. 1991 Human immunodeficiency virus genetic variation that can escape cytotoxic T-cell recognition. Nature (London) 354:453-459.
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
40. Sardana, V. V., A. J. Schlabach, P. Graham, B. L. Bush, J. H. Condra, J. C. Culberson, L. Gotlib, D. J. Graham, N. E. Kohl, R. L. LaFemina, C. L. Schneider, B. S. Wolanski, J. A. Wolfgang, and E. A. Emini. 1994 Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding site. Biochemistry 33:2004-2010
41. Simmonds, P., L. Q. Zhang, F. McOmish, P. Balfe, C. A. Ludlam, and A. J. Leigh Brown. 1991. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyteassociated proviral populations in vivo: implications for models of HIV pathogenesis. J. Virol. 65:6266-6276.
42. St. Clair, M. H., J. L. Martin, G. Tudor-Williams, M. C. Bach, C. L. Vavro, D. M. King, P. Kellam, S. D. Kemp, and B. A. Larder. 1991. Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 253:1557-1559.
43. Tomasseili, A. G., W. J. Howe, T. K. Sawyer, A. Wlodawer, and R. L. Heinrikson. 1991. The complexities of AIDS' an assessment of the HIV protease as a therapeutic target Chim. Oggi. 2:6-27.
44. Turriziani, O., G. Antonelli, H. Jacobsen, J. Mous, E. Riva, M. Pistello, and F. Dianzani. 1994. Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase. Acta Virol. 38:297-298.
45. Vartanian, J. P., A. Meyerhans, M. Henry, and S. Wain-Hobson. 1992. High resolution structure of an HIV-1 quasispecies: identification of non-coding sequences. AIDS 6:1095-1098.
46. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
47. Winslow, D. L., S. Stack, R. King, H. Scarnati, A. Bincsik, and M. J. Otto. 1995. Limited sequence diversity of the HIV type 1 protease gene from clinical isolates and in vitro susceptibility to HIV protease inhibitors AIDS Res. Hum. Retroviruses 11:107-113
48. Wlodawer, A., and J. Erickson. 1993. Structure-based inhibitors of the HIV-1 protease. Annu Rev. Biochem. 62:543-585.
49. Yang, Y. L., Q. Wang, K. Dorman, and A. H. Kaplan. Long PCR amplification of heterogeneous HIV-1 templates results in recombination at a high frequency. AIDS Res. Hum. Retroviruses, in press.
50. Zhang, L. Q., P. Mackenzie, A. Cleland, E. C. Holmes, A. J. Leigh Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol 67:3345-3356.